Cellectis

is a France-based biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer...
Read more
Cellectis CEO: Andre Choulika

CEO

Andre Choulika

CEO Approval Rating

89/100

Annual Revenue
$12.1M
Employees
221
Funding
$1B

Cellectis Competitors

1Kite Pharma
2CRISPR
3Fate Therapeutics
4Atara
5bluebird bio
6Juno Therapeutics
7Novartis
8Johnson & Johnson
9Precision BioSciences
10Regeneron

Trending Companies